Asset Purchase Agreement under which Erigen sold assets to the Company in exchange for shares of common stock
| Officer | Age | In this role | Source |
|---|---|---|---|
|
Matthew Angel
Also a director
President, Chief Executive Officer and Chair of the Board
|
45 | Not stated | |
|
Stephanie Horn-Warnock
Chief Financial Officer, Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary
|
37 |
Since 2026
this year
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Asset Purchase Agreement under which Erigen sold assets to the Company in exchange for shares of common stock
Factor funding commitment to provide financial support to the Company
Exclusive license and collaboration agreement assigned to the Company, with milestone and royalty payments
Amended and restated license and collaboration agreement assigned to the Company, with milestone and royalty payments
Amended and restated master services agreement under which Factor provides services on a fee-for-services basis
Work Order No. 1 for research and development services through March 31, 2027, with fees waived in part
2026 Master Services Agreement under which Factor provides research and development services for fees
Sale of shares and warrants to Factor in the private placement
Company settled Erigen legal fees incurred before the Erigen closing with WSGR, recorded as G&A expense
Professional Services Agreement under which YQ provides business development and corporate development services at hourly rates
Loading...